Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
about
Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsFebrile-range hyperthermia accelerates caspase-dependent apoptosis in human neutrophilsNasal polyposis: eosinophils and interleukin-5.In vivo paradigms of diseased airway mucosa: selected aspects of innate immunity and eosinophils.Nedocromil sodium: a review of the evidence for a dual mechanism of action.New aspects of degranulation and fates of airway mucosal eosinophils.Eosinophil apoptosis--pathophysiologic and therapeutic implications.Mitochondria in eosinophils: functional role in apoptosis but not respiration.Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5.Novel targeted therapies for eosinophil-associated diseases and allergyType 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract.Eosinophils and atopic dermatitis.Genes of tolerance.Targets in allergy-directed immunotherapy.Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.Disruption of fas receptor signaling by nitric oxide in eosinophils.A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice.Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.Novel immunotherapeutic approaches for allergy and asthma.Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EoL-1 cells.Pathophysiologic role of alpha 4 integrins in the lung.Epithelium, microcirculation, and eosinophils--new aspects of the allergic airway in vivo.The role of cytokines in infectious sinusitis and nasal polyposis.Excretory-secretory product of newly excysted metacercariae of Paragonimus westermani directly induces eosinophil apoptosis.Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration.Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment.Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitro.Experimental common cold increases mucosal output of eotaxin in atopic individuals.Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5.Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.Enhanced expression of GM-CSF in differentiating eosinophils of atopic and atopic asthmatic subjects.Assessment of tumor growth factor-β1 neutralizing antibody in the treatment of allergic rhinitis and asthma.Wentong decoction cures allergic bronchial asthma by regulating the apoptosis imbalance of EOS.Apoptosis signals in atopy and asthma measured with cDNA arraysInterleukin-5 deficient mice exhibit impaired host defence against challenge Trichinella spiralis infections
P2860
Q26799532-837B3DD6-634F-401A-B2A5-567F3F11A7C5Q33693890-26DECD75-5B1C-4F53-BAA8-519815862CECQ33708508-262D9687-0DE9-4755-89C8-F828E6410B92Q33775596-7F8D7C1D-5533-41E7-97A6-C75D56A9A696Q33863949-B158D136-AF44-4B6E-96DE-3BACFE2518E6Q33942417-F7603F5B-9E4F-48A8-B770-88761D6A5BB2Q34059300-B7FCB15D-CA18-4448-819A-238C010C619FQ34099713-1766511C-3EEE-4D1D-B973-84D2A6DC48C5Q34432617-0F4CA8C2-8540-4047-8E51-073522262FA6Q34444620-D35406DE-C1FD-481A-9BB7-9AC14FE0F05EQ35372676-3DD86828-6CBD-44D4-88B8-FE87B4F4E684Q35607573-43CB5A11-5D9F-496E-AE81-F0E824F9BC3FQ35775340-8926E89A-A26E-4809-862E-6A62D1C753ADQ35855013-44F8A337-54AC-4F59-A565-8EA6402DB4A3Q36150810-516B8AC0-5199-4DAC-9C92-0DE09880548AQ36365810-408BAC5A-43A6-465E-BBA3-A801285AE358Q36400192-69BEAB75-8BA6-480D-B97C-CD19454C079DQ37190240-43EDDF92-A5BF-47B6-B699-CC7201CF6B32Q37709674-074A01C0-C31F-4332-856A-91A277342926Q37728000-F8ECDA0A-545C-4638-B1F9-231CF8C91205Q40915989-FBB74277-2306-4666-BE45-FCC566FBEB66Q40923050-CC9AA841-5C5A-4C14-B922-31B8842FC7F8Q41462058-D693EFC2-4A2E-44C3-B0F6-2893682EF39CQ41716101-90A6DC1E-9642-4EC4-835D-3C572F310B55Q41994392-7AFDE358-403B-44A0-9CD6-B26DDD2B19A0Q42014635-A3F5ACA7-8595-4CA6-AF0D-55F34E850540Q42459337-474A169D-D94B-4524-80EA-DBC9D44423A8Q42943439-38CCE032-947E-43BE-B478-EDAD8B37E782Q43816373-DCF80CEC-4B80-4381-BEFC-EFA8620CAFF9Q44163591-BAF78735-51CE-4B8D-A930-ACE8DA7F921EQ44445399-C4460E06-F510-4408-8FF8-393509D1ADA1Q46407194-C8FC66B6-6D6D-4D92-A407-F2849BA76C4AQ46787777-1AF33755-240D-4F76-8190-A738DDCB38F4Q47892914-9A9E0A9D-AFF8-4596-8854-62105EC32BF5Q49199375-18FEA535-C08E-4ED5-A081-8305947E5C94Q53689680-5B1533D3-4083-49EF-92E4-9B5453F48208Q57007921-AAF74783-EDA5-4F90-9E4C-A47159F5FB91Q58061417-A85D7903-CF68-4A6E-B09D-47376659B837
P2860
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
@en
type
label
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
@en
prefLabel
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
@en
P1433
P1476
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
@en
P2093
P356
10.1016/0167-5699(95)80086-7
P577
1995-02-01T00:00:00Z